Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

The global pandemic of coronavirus disease 2019 (COVID‐19) is associated with the development of acute respiratory distress syndrome (ARDS), which requires ventilation in critically ill patients. The pathophysiology of ARDS results from acute inflammation within the alveolar space and prevention of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thromb Haemost
Autors principals: Whyte, Claire S., Morrow, Gael B., Mitchell, Joanne L., Chowdary, Pratima, Mutch, Nicola J.
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2020
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264738/
https://ncbi.nlm.nih.gov/pubmed/32329246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14872
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars